The Indus Health Network (IHN) has installed a new and most modern Martin Dow Total Lab Automation (TLA) system supplied by Abbott Diagnostics in the Korangi Campus. This state-of-the-art system has been installed with the support of Martin Dow Group which helped IHN in building the laboratory and associated facilities. IHN treats about 200,000 patients monthly and the strategic partnership with Martin Dow group will help IHN to serve more patients. The inauguration ceremony took place on December 24, 2018 at The Indus Hospital (TIH), Korangi. Dr. Abdul Bari Khan, Chief Executive Officer, IHN spoke at the event, “IHN is grateful for the cooperation from Martin Dow Group –our strategic partner – for setting up the TLA. I’m especially thankful to Late Mr. M. Jawed Akhai, Founding Chairman, Martin Dow Group for his utmost support to the cause of the Indus Hospital. He was actively involved with IHN in extending a helping hand for the marginalized segment of the society. We value his exceptional contribution and would always remember his untiring efforts to help the poor and needy of the country.”
Mr. A. Sattar Akhai, Group Chairman Martin Dow, graced the occasion as the chief guest and inaugurated the facility by ribbon cutting. Speaking to the gathering Mr. Ali Akhai,Chairman Martin Dow Group said,“Technology drives healthcare more than any other force, and in the future, it will continue to develop in dramatic ways. While we can glimpse and debate the details of future trends in healthcare, we need to be clear about the drivers, so we can align with them and actively work to ensure the best outcomes for society. Martin Dow Group will continue supporting initiatives like these to strengthen the healthcare system of Pakistan”.
Dr. Saba Jamal, Director Indus Blood Center elaborated, “The new Alinity system is a hitech and advanced automation system which will increase Indus Hospital’s capacity to perform diagnostic analysis. The automated scalable solutions will enhance laboratory operations through consolidation of space and would also adapt to varying requirements for efficient use of capital and resources, thus enabling the lab to run at its best today and into the future.”
At Indus, the current monthly average load of chemical pathology is 80,000 tests and it is estimated that with the new TLA system its efficiency and efficacy will increase 30 times.
The new Martin Dow Total Lab Automation, harmonized family of systems for clinical diagnostics that provides screening ability for immunoassay, clinical chemistry, point of care, haematology, blood and plasma and molecular diagnostics.
The TLA will help IHN in meeting its changing clinical needs, increasing operational efficiency, advancing workflow capabilities,and improving productivity at lower cost. The inauguration ceremony was attended by members of the Board of Directors, IHN;heads of departments, faculty and staff along with the senior officials of Martin Dow group and Abbott Diagnostics.